Crossmark

The effect of continuing versus withholding angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers on mortality and major adverse cardiovascular events in hypertensive patients undergoing elective non-cardiac surgery: study protocol for a multi-centric open-label randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-022-06616-y

Published Online: 2022-08-17

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Misra, Satyajeet https://orcid.org/0000-0001-8097-0338
Parida, Satyen

Sahajanandan, Raj

Behera, Bikram Kishore

Senthilnathan, Muthapillai

Mariappan, Ramamani

Chandy, Tony Thomson

,
Funding

Funding for this research was provided by:

Indian Council of Medical Research (2020-4671)
License Information

Text and Data Mining valid from 2022-08-17

Version of Record valid from 2022-08-17
More Information

Article History

Received: 20 March 2022

Accepted: 2 August 2022

First Online: 17 August 2022

Declarations

:

: Included in the manuscript.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below